Allurion Tech Stock
StockStockPrice
Frequently asked questions
What is Allurion Tech's market capitalization?
What is the Earnings Per Share (EPS) for Allurion Tech?
What are the analyst ratings and target price for Allurion Tech's stock?
What is Allurion Tech's revenue over the trailing twelve months?
What is the EBITDA for Allurion Tech?
What is the free cash flow of Allurion Tech?
What is the 5-year beta of Allurion Tech's stock?
How many employees does Allurion Tech have, and what sector and industry does it belong to?
What is the free float of Allurion Tech's shares?
Financials
Market Cap
$45.80M5Y beta
-0.34EPS (TTM)
-$0.877Free Float
48.65MRevenue (TTM)
$47.59MEBITDA (TTM)
-$71.72MFree Cashflow (TTM)
-$63.27MPricing
Analyst Ratings
The price target is $5.00 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
Allurion Technologies, Inc. offers Allurion Program, which is a weight loss platform that combines the Allurion Gastric Balloon for weight loss. The Company offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.
249
Software & Programming
Information Technology
Identifier
ISIN
Primary Ticker